// App-Quantinova.ai

Su1472 : Clinical Outocomes of Interferon Administration in Combination With Sorafenib in Patients With Recurrent Advanced Hepatits C-Related Hepatocellular Carcinoma

Researchers

Presenter

  • Hisakazu Doi

Principal Investigators

  • N/A

Medical Centers

  • Gastroenterology and Hepatology, Nagahama Red Cross Hospital, Nagahama, Shiga, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Hepatitis C

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • Interferon

Drug/Treatment

  • Interferon

  • Sorafenib

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved